RxSight, Inc.
NASDAQ: RXST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ronald Kurtz
- Employees
- 498
- Headquarters
- Aliso Viejo, United States
- IPO year
- 2021
- Market cap
- $219.8M
- Website
- https://www.rxsight.com
Loading RXST…
Loading profile data…Frequently asked questions about RXST
What does RxSight, Inc. (RXST) do?
As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domest...
Where does RXST trade?
RxSight, Inc. (RXST) trades on the NASDAQ Global Market.
What sector is RXST in?
RxSight, Inc. (RXST) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of RxSight, Inc.?
Ronald Kurtz is the chief executive officer of RxSight, Inc. (RXST).
Where is RxSight, Inc. headquartered?
RxSight, Inc. is headquartered in United States.
Does RXST pay a dividend?
RxSight, Inc. (RXST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RXST go public?
RxSight, Inc. (RXST) completed its initial public offering in 2021.